I. Athanasiou

发表

QR-313, an antisense oligonucleotide, shows therapeutic efficacy for treatment of dominant and recessive dystrophic epidermolysis bullosa: a preclinical study.

T. Ritsema, D. Keene, J. Bischof, 2020, The Journal of investigative dermatology.

Postpartum thrombotic microangiopathy revealed as atypical hemolytic uremic syndrome successfully treated with eculizumab: a case report

Kyriakos I. Ioannou, Michalis Zavros, I. Athanasiou, 2014, Journal of Medical Case Reports.

Case Report: Diagnostic and Therapeutic Challenges in Severe Mechanobullous Epidermolysis Bullosa Acquisita

M. Kunz, J. Fischer, C. Has, 2022, Frontiers in Immunology.

Novel PLEC Variant Causes Only Mild Skin Fragility, but Pyloric Atresia, Muscular Dystrophy and Urological Manifestations.

C. Kanaka-Gantenbein, R. Pons, D. Kiritsi, 2019, Acta dermato-venereologica.

Treatment of keratinocytes with 4-phenylbutyrate in epidermolysis bullosa: Lessons for therapies in keratin disorders

Richard C. Gerum, B. Fabry, J. Dengjel, 2019, EBioMedicine.

Combinatorial Omics Analysis Reveals Perturbed Lysosomal Homeostasis in Collagen VII-deficient Keratinocytes*

T. Reinheckel, R. Backofen, J. Dengjel, 2018, Molecular & Cellular Proteomics.

A new clinical variant of acquired reactive perforating dermatosis‐like bullous pemphigoid

H. Shimizu, F. Schauer, L. Bruckner-Tuderman, 2018, The British journal of dermatology.

Proteomic profiling of fibroblasts isolated from chronic wounds identifies disease-relevant signaling pathways.

J. Dengjel, C. Gretzmeier, Kerstin Thriene, 2020, The Journal of investigative dermatology.

Combinatorial Omics Analysis Reveals Perturbed Lysosomal Homeostasis in Collagen VII-deficient Keratinocytes*

T. Reinheckel, R. Backofen, J. Dengjel, 2018, Molecular & Cellular Proteomics.